CompaniesInnogenetics

Innogenetics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

3,107

By Phase

NA: 2PHASE1: 2

By Status

COMPLETED: 4UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details

Recent Trials

NCT06096103Collaborator
A Clinical Study to Check the Safety and Effectiveness of Botanical Extract Standardized for Iron + Vitamin C and Botanical Extract Standardized for Iron in Adult Human Subjects with Anemia or Iron-deficiency Anemia
NACompleted
96 participants
Started: Nov 3, 2023 · Completed: Feb 9, 2024
NCT05972512Collaborator
A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin with Silica in Healthy Human Subjects with Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin
NACompleted
105 participants
Started: Aug 22, 2023 · Completed: Dec 14, 2023
NCT05939271Collaborator
Lower Extremity Amputations in Persons With Diabetes Mellitus in the Netherlands
N/AUnknown
2,808 participants
Started: Sep 1, 2022 · Completed: Dec 1, 2023
NCT01283490Collaborator
The Effect of Sonophoresis on Topical Anesthesia: A Pilot Study
PHASE1Completed
50 participants
Started: Feb 28, 2011 · Completed: Dec 31, 2012
NCT01188512Collaborator
First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine
PHASE1Completed
48 participants
Started: Aug 31, 2010 · Completed: Jan 31, 2012
Related Companies
Fujirebio Europe
acquired